EP3498725
19-nor C3,3-tvísetinn C21-N-pýrasólýl-steri til notkunar í meðferð
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
17.4.2014EP published:
9.6.2021EP application number:
18203320.9
EP translation filed:
24.8.2021Grant published:
15.9.2021EPO information:
European Patent Register
Max expiry date:
16.4.2034Expiry date:
16.4.2026Next due date:
30.4.2026
Title:
19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID FOR USE IN THERAPY
Timeline
Today
17.4.2014EP application
9.6.2021EP Publication
24.8.2021Translation submitted
15.9.2021Registration published
16.4.2026Expires
Owner
Name:
Sage Therapeutics, Inc.Address:
215 First Street, Cambridge, MA 02142, US
Inventor
Name:
BOTELLA, Gabriel MartinezAddress:
Wayland, Massachusetts 01778, US
Name:
HARRISON, Boyd, L.Address:
Princeton Junction, New Jersey 08550, US
Name:
ROBICHAUD, Albert, JeanAddress:
Ringoes, New Jersey 08551, US
Name:
SALITURO, Francesco G.Address:
Marlborough, Massachusetts 01752, US
Name:
BERESIS, Richard ThomasAddress:
Shanghai, 200040, CN
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
PCT/CN2013/074323Date:
17.4.2013Country:
WO
Classification
Categories:
C07J 43/00, A61K 31/57, A61K 31/573, A61K 31/58, A61P 25/00, C07J 3/00, C07J 7/00, C07J 15/00, C07J 1/00, C07J 5/00, C07J 13/00, C07J 21/00, C07J 31/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 10.3.2022
Expires: 16.4.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 8.3.2023
Expires: 16.4.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 7.3.2024
Expires: 16.4.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 14.3.2025
Expires: 16.4.2026
Payer: Árnason Faktor ehf.